Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WTO Rx Compulsory Licensing Agreement Solves “Symbolic” Issue, USTR Says

Executive Summary

World Trade Organization final agreement on drug compulsory licensing represents progress on a "symbolic" issue, Assistant U.S. Trade Representative for Services, Investment and Intellectual Property James Mendenhall said Sept. 2 at an American Enterprise Institute forum on the Trade-Related Aspects of Intellectual Property Rights agreement
Advertisement

Related Content

Rx Pricing Debate Must Be Framed As Trade Issue, Pfizer CEO Says
Rx Pricing Debate Must Be Framed As Trade Issue, Pfizer CEO Says
PhRMA Prepares For More TRIPS Import Talks; U.S. Lays Out “Interim Plan”
PhRMA Prepares For More TRIPS Import Talks; U.S. Lays Out “Interim Plan”
Advertisement
UsernamePublicRestriction

Register

PS042443

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel